UB Paderborn / Katalog / Suche / in CDI

Sortiert nach

Einfacher Volltextzugriff von (fast) überall

Installieren Sie die LibKey Nomad-Browsererweiterung und erhalten Sie von vielen Webseiten einfachen Zugriff auf lizenzierte Volltexte oder Open Access Publikationen. Mehr erfahren...

Contemporary Characteristics and Outcomes in Chagasic Heart Failure Compared With Other Nonischemic and Ischemic Cardiomyopathy

Circulation. Heart failure, 2017-11, Vol.10 (11)

2017

Volltextzugriff (PDF)

Dimethyl Fumarate and Monomethyl Fumarate Promote Post-Ischemic Recovery in Mice

Translational stroke research, 2016-12, Vol.7 (6), p.535-547

2016

Volltextzugriff (PDF)

Prognostic Value of N-Terminal Pro-B-Type Natriuretic Peptide Levels in Heart Failure Patients With and Without Atrial Fibrillation

Circulation. Heart failure, 2017-10, Vol.10 (10)

2017

Volltextzugriff (PDF)

Switching from a fumaric acid ester mixture to dimethylfumarate monotherapy in psoriasis

Journal of the European Academy of Dermatology and Venereology, 2019-10, Vol.33 (10), p.e352-e353

2019

Volltextzugriff (PDF)

Budesonide/Glycopyrrolate/Formoterol Fumarate Co-suspension Metered Dose Inhaler: A Triple Therapy for the Treatment of Chronic Obstructive Pulmonary Disease

The Annals of pharmacotherapy, 2022-05, Vol.56 (5), p.582-591

2022

Volltextzugriff (PDF)

Recent advances in the biomedical applications of fumaric acid and its ester derivatives: The multifaceted alternative therapeutics

Pharmacological reports, 2016-04, Vol.68 (2), p.404-414

2016

Volltextzugriff (PDF)

New insights in the targets of action of dimethyl fumarate in endothelial cells: effects on energetic metabolism and serine synthesis in vitro and in vivo

Communications biology, 2023-10, Vol.6 (1), p.1084-14, Article 1084

2023

Volltextzugriff (PDF)

Efficacy and Safety of Budesonide/Glycopyrronium/Formoterol Fumarate versus Other Triple Combinations in COPD: A Systematic Literature Review and Network Meta-analysis

Advances in therapy, 2021-06, Vol.38 (6), p.3089-3112

2021

Volltextzugriff (PDF)

Budesonide/formoterol maintenance and reliever therapy versus fluticasone/salmeterol fixed-dose treatment in patients with COPD

Thorax, 2023-05, Vol.78 (5), p.451-458

2023

Volltextzugriff (PDF)

Cost‐utility of as‐needed combination low‐dose budesonide‐formoterol in adolescents mild asthma

Pediatric pulmonology, 2021-12, Vol.56 (12), p.3699-3705

2021

Volltextzugriff (PDF)

New Versus Old: The Impact of Changing Patterns of Inhaled Corticosteroid Prescribing and Dosing Regimens in Asthma Management

Advances in therapy, 2022-05, Vol.39 (5), p.1895-1914

2022

Volltextzugriff (PDF)

Direct healthcare costs associated with management of asthma: comparison of two treatment regimens in Indonesia, Thailand and Vietnam

The Journal of asthma, 2022-06, Vol.59 (6), p.1213-1220

2022

Volltextzugriff (PDF)

May a different kinetic mode explain the high efficacy/safety profile of inhaled budesonide?

Pulmonary pharmacology & therapeutics, 2022-12, Vol.77, p.102167, Article 102167

2022

Volltextzugriff (PDF)

Patterns of Asthma Medication Use in New Zealand After Publication of National Asthma Guidelines

The journal of allergy and clinical immunology in practice (Cambridge, MA), 2023-09, Vol.11 (9), p.2757-2764.e5

2023

Volltextzugriff (PDF)

European S3-Guidelines on the systemic treatment of psoriasis vulgaris - Update 2015 - Short version - EDF in cooperation with EADV and IPC

Journal of the European Academy of Dermatology and Venereology, 2015-12, Vol.29 (12), p.2277-2294

2015

Volltextzugriff (PDF)

Beginning to Address an Implementation Gap in Asthma: Clinicians’ Views of Prescribing Reliever Budesonide-Formoterol Inhalers and SMART in the United States

The journal of allergy and clinical immunology in practice (Cambridge, MA), 2023-09, Vol.11 (9), p.2767-2777

2023

Volltextzugriff (PDF)

Effectiveness and quality of life in asthmatic patients treated with budesonide/formoterol via Elpenhaler® device in primary care. The "SKIRON" real world study

The Journal of asthma, 2023-06, Vol.60 (6), p.1104-1114

2023

Volltextzugriff (PDF)

Placebo-Controlled Phase 3 Study of Oral BG-12 or Glatiramer in Multiple Sclerosis

The New England journal of medicine, 2012-09, Vol.367 (12), p.1087-1097

2012

Volltextzugriff (PDF)

Placebo-Controlled Phase 3 Study of Oral BG-12 for Relapsing Multiple Sclerosis

The New England journal of medicine, 2012-09, Vol.367 (12), p.1098-1107

2012

Volltextzugriff (PDF)

Evaluation of Budesonide-Formoterol for Maintenance and Reliever Therapy Among Patients With Poorly Controlled Asthma: A Systematic Review and Meta-analysis

JAMA network open, 2022-03, Vol.5 (3), p.e220615-e220615

2022

Volltextzugriff (PDF)

Targeting immunometabolism as an anti-inflammatory strategy

Cell research, 2020-04, Vol.30 (4), p.300-314

2020

Volltextzugriff (PDF)

Efficacy of Budesonide/Glycopyrronium/Formoterol Fumarate Metered Dose Inhaler (BGF MDI) Versus Other Inhaled Corticosteroid/Long-Acting Muscarinic Antagonist/Long-Acting β 2 -Agonist (ICS/LAMA/LABA) Triple Combinations in COPD: A Systematic Literature Review and Network Meta-analysis

Advances in therapy, 2020-06, Vol.37 (6), p.2956

2020

Volltextzugriff (PDF)

Cardiorenal End Points in a Trial of Aliskiren for Type 2 Diabetes

The New England journal of medicine, 2012-12, Vol.367 (23), p.2204-2213

2012

Volltextzugriff (PDF)

1 – 25 von 4.599

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(4.211)
Mit Volltextzugriff
(3.283)

Publikationsform

Sprache

15 weitere anzeigen...

Weniger anzeigen...

Erscheinungsjahr

n.n

Thema

Humans
(4.349)
Science & Technology
(3.742)
Life Sciences & Biomedicine
(3.670)
Male
(2.396)
Female
(2.306)
Adult
(1.825)
Antipsychotic Agents - Therapeutic Use
(1.623)
Quetiapine Fumarate
(1.565)
Middle Aged
(1.529)
Dibenzothiazepines - Therapeutic Use
(1.459)
Psychiatry
(1.187)
Treatment Outcome
(1.146)
Pharmacology & Pharmacy
(1.044)
Biological And Medical Sciences
(1.004)
Medical Sciences
(994)
Aged
(929)
Fumarates - Therapeutic Use
(923)
Antipsychotic Agents - Adverse Effects
(775)
Drug Therapy, Combination
(687)
Pharmacology. Drug Treatments
(681)

15 weitere anzeigen...

Weniger anzeigen...

Kollektion

MEDLINE
(4.595)
Journals@Ovid Complete
(1.998)
Ingenta
(1.975)
EZB Electronic Journals Library
(1.595)
IngentaConnect Journals
(1.071)
NUS Single-Journal Subscriptions
(1.028)
Elsevier ScienceDirect Journals Complete
(821)
Wiley Online Library Journals
(600)
Elsevier Journal Backfiles on ScienceDirect (DFG Nationallizenzen)
(594)
Springer Journals
(490)
Wiley Online Library Full Collection 2018
(422)
Taylor & Francis Journals
(369)
Taylor & Francis
(289)
Taylor & Francis Journals Complete
(284)
SAGE Publications
(242)
SpringerLINK Contemporary (Konsortium Baden-Württemberg)
(233)
Psychology and Behavioral Sciences Collection
(181)
Oxford University Press Journals Current
(141)
Nexis Uni
(113)
SpringerLink Series
(100)

15 weitere anzeigen...

Weniger anzeigen...

Neu hinzugefügt

... seit 30 Tagen
(4)
... seit 90 Tagen
(15)

Menü

Weitere Dienste

Einstellungen

Diroximel Fumarate Demonstrates an Improved Gastrointestinal Tolerability Profile Compared with Dimethyl Fumarate in Patients with Relapsing–Remitting Multiple Sclerosis: Results from the Randomized, Double-Blind, Phase III EVOLVE-MS-2 Study

Contemporary Characteristics and Outcomes in Chagasic Heart Failure Compared With Other Nonischemic and Ischemic Cardiomyopathy

Dimethyl Fumarate and Monomethyl Fumarate Promote Post-Ischemic Recovery in Mice

Prognostic Value of N-Terminal Pro-B-Type Natriuretic Peptide Levels in Heart Failure Patients With and Without Atrial Fibrillation

Switching from a fumaric acid ester mixture to dimethylfumarate monotherapy in psoriasis

Budesonide/Glycopyrrolate/Formoterol Fumarate Co-suspension Metered Dose Inhaler: A Triple Therapy for the Treatment of Chronic Obstructive Pulmonary Disease

Recent advances in the biomedical applications of fumaric acid and its ester derivatives: The multifaceted alternative therapeutics

New insights in the targets of action of dimethyl fumarate in endothelial cells: effects on energetic metabolism and serine synthesis in vitro and in vivo

Efficacy and Safety of Budesonide/Glycopyrronium/Formoterol Fumarate versus Other Triple Combinations in COPD: A Systematic Literature Review and Network Meta-analysis

Budesonide/formoterol maintenance and reliever therapy versus fluticasone/salmeterol fixed-dose treatment in patients with COPD

Cost‐utility of as‐needed combination low‐dose budesonide‐formoterol in adolescents mild asthma

Dupilumab efficacy and safety in adults with uncontrolled persistent asthma despite use of medium-to-high-dose inhaled corticosteroids plus a long-acting β2 agonist: a randomised double-blind placebo-controlled pivotal phase 2b dose-ranging trial

New Versus Old: The Impact of Changing Patterns of Inhaled Corticosteroid Prescribing and Dosing Regimens in Asthma Management

Direct healthcare costs associated with management of asthma: comparison of two treatment regimens in Indonesia, Thailand and Vietnam

May a different kinetic mode explain the high efficacy/safety profile of inhaled budesonide?

Patterns of Asthma Medication Use in New Zealand After Publication of National Asthma Guidelines

European S3-Guidelines on the systemic treatment of psoriasis vulgaris - Update 2015 - Short version - EDF in cooperation with EADV and IPC

Beginning to Address an Implementation Gap in Asthma: Clinicians’ Views of Prescribing Reliever Budesonide-Formoterol Inhalers and SMART in the United States

Effectiveness and quality of life in asthmatic patients treated with budesonide/formoterol via Elpenhaler® device in primary care. The "SKIRON" real world study

Placebo-Controlled Phase 3 Study of Oral BG-12 or Glatiramer in Multiple Sclerosis

Placebo-Controlled Phase 3 Study of Oral BG-12 for Relapsing Multiple Sclerosis

Evaluation of Budesonide-Formoterol for Maintenance and Reliever Therapy Among Patients With Poorly Controlled Asthma: A Systematic Review and Meta-analysis

Targeting immunometabolism as an anti-inflammatory strategy

Efficacy of Budesonide/Glycopyrronium/Formoterol Fumarate Metered Dose Inhaler (BGF MDI) Versus Other Inhaled Corticosteroid/Long-Acting Muscarinic Antagonist/Long-Acting β 2 -Agonist (ICS/LAMA/LABA) Triple Combinations in COPD: A Systematic Literature Review and Network Meta-analysis

Cardiorenal End Points in a Trial of Aliskiren for Type 2 Diabetes

Suchergebnisse filtern